JAK1 Activates STAT3 Activity in Non-Small–Cell Lung Cancer Cells and IL-6 Neutralizing Antibodies Can Suppress JAK1-STAT3 SignalingLanxi Song, Eric B. Haura|Molecular Cancer Therapeutics|2011Cited by 180
ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung CancerTakeshi Yoshida, Eric B. Haura|PLoS ONE|2016Cited by 98
Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling NetworksIshwar N. Kohale, Forest M. White, Danielle M. Burgenske et al.|Cancer Research|2021Cited by 37
Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry–Based Phosphotyrosine ProteomicsScott M. Haake, Eric B. Haura|Clinical Cancer Research|2016Cited by 24
Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung CancerCasey Liveringhouse, Bradford A. Perez, Gretchen V. MacMillan et al.|International Journal of Radiation Oncology*Biology*Physics|2023Cited by 18